China: The global burden of interstitial lung disease and pulmonary sarcoidosis (ILD&PS) has increased sharply between 1990 and 2021, with India ranking among the top three countries in terms of both prevalence and mortality. In 2021 alone, the country recorded over 6.5 lakh cases and nearly 47,000 deaths related to ILD&PS. The disease was most common among individuals aged over 50 years and showed higher rates in men. Projections indicate that the burden will continue to rise steadily until 2040. The findings are from a study published in Frontiers in Medicine by Xinxin Zhang and colleagues from The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China. The researchers conducted a comprehensive assessment of ILD&PS burden globally, regionally, and

See Full Page